GlassScriptPhysician profile
Jack D Schillen
NPI 1265401541
$14,497.96
in general payments reported to CMS, 2019-2025
13 companies · $1,565 in 2025
The $1,565 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,893 · 2020: $2,407 · 2021: $2,490 · 2022: $5,537 · 2023: $402 · 2024: $204 · 2025: $1,565.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,329 · Food and Beverage: $841.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,329.44 |
| Food and Beverage | $841.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Steelhead Surgical INC | $10,139.13 | 2019-2023 | |
| Arthrex, INC. | $2,122.16 | 2019-2022 | |
| Miach Orthopaedics, INC. | $1,624.71 | 2023-2025 | |
| Pacira Therapeutics, INC. | $208.48 | 2019-2021 | |
| Stryker Corporation | $117.31 | 2024 | Alphavent |
| Pacira Pharmaceuticals Incorporated | $83.06 | 2023-2024 | Zilretta, Iovera, Exparel |
| Bioventus LLC | $53.81 | 2021-2024 | Supartz Fx Sodium Hyaluronate |
| Merck Sharp & Dohme LLC | $52.90 | 2022-2024 | Bridion |
| Vertex Pharmaceuticals Incorporated | $29.97 | 2025 | |
| Ethicon US, LLC | $20.14 | 2025 | Stratafix, Vistaseal, Ethicon |
| Baudax Bio INC. | $17.11 | 2021 | |
| Depuy Synthes Sales INC. | $14.72 | 2022 | |
| Boston Scientific Corporation | $14.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Schillen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.